SUPN — Supernus Pharmaceuticals, Inc. stock price, charts and financials

QT40Supernus Pharmaceuticals, Inc.

Supernus Pharmaceuticals, Inc. (NASDAQ: SUPN) is a Healthcare company in the Drug Manufacturers - Specialty & Generic industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
42.00
-0.92-2.14%
OverviewShort InterestFilings
SUPNQT40Supernus Pharmaceuticals, Inc.·NASDAQ
42.00-2.14%

Latest SEC Filings

Form category
Filing Date ▾FormDescriptionFilingDocument
Sep 11, 2026DEFM14ADefinitive proxy statement (merger)
Aug 14, 20264Statement of changes in beneficial ownership
Aug 14, 20264Statement of changes in beneficial ownership
Aug 14, 20264Statement of changes in beneficial ownership
Aug 14, 20264Statement of changes in beneficial ownership
Aug 14, 20264Statement of changes in beneficial ownership
Aug 06, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Aug 04, 2026425Prospectus / business-combination communication
Aug 03, 20268-KCurrent report
Aug 03, 20268-KCurrent report
Aug 03, 20268-KCurrent report
Aug 03, 2026DEFA14AAdditional proxy soliciting materials
Aug 03, 2026425Prospectus / business-combination communication
Aug 03, 2026425Prospectus / business-combination communication
Aug 03, 202610-QQuarterly report
Aug 03, 2026425Prospectus / business-combination communication
Aug 03, 20268-KCurrent report
Aug 03, 2026DEFA14AAdditional proxy soliciting materials
Aug 03, 2026425Prospectus / business-combination communication
Aug 03, 2026DEFA14AAdditional proxy soliciting materials
Jul 31, 20264Statement of changes in beneficial ownership
Jul 31, 20264Statement of changes in beneficial ownership
Jul 31, 20264Statement of changes in beneficial ownership
Jul 31, 20264Statement of changes in beneficial ownership
Jul 31, 20264Statement of changes in beneficial ownership
#1 / 25 of 468
Page
▼
/ 19